Illumina (ILMN) Said to Have Purchase Moleculo, Inc.
Tweet
Share
E-mailGet Alerts ILMN Hot Sheet
Join SI Premium – FREE
Illumina, Inc. (NASDAQ: ILMN) said it purchase Moleculo, Inc. The news comes as it filed an 8-K earlier disclosing that it withdrew its offer for Complete Genomics (Nasdaq: GNOM).
The biotech is presenting at the JPMorgan Global Healthcare Conference today. Shares are up 1.8 percent on the session.
The biotech is presenting at the JPMorgan Global Healthcare Conference today. Shares are up 1.8 percent on the session.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nscale targets up to $3B in US IPO as soon as September - Bloomberg
- General Fusion lists on Nasdaq via SPAC merger with $150M in cash
- Trustar Bank to acquire Forbright Bank branches for $750M in deposits
Create E-mail Alert Related Categories
Insiders' Blog, Mergers and AcquisitionsRelated Entities
JPMorganSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
